• Title/Summary/Keyword: 무월경

Search Result 80, Processing Time 0.023 seconds

Swyer Syndrome: A Case Report (Swyer 증후군: 증례 보고)

  • Hyeong Gi Choi;Sohoon Park
    • Journal of the Korean Society of Radiology
    • /
    • v.84 no.5
    • /
    • pp.1181-1184
    • /
    • 2023
  • Swyer syndrome is a rare form of primary amenorrhea resulting from gonadal dysgenesis. It is characterized by the presence of a female phenotype with a 46, XY karyotype. In our case, CT scans revealed the absence of the uterus and bilateral ovaries of the 16-year-old female patient. Calcific nodules were found in both inguinal areas, which were suspected to be calcified atrophic testes. A chromosomal study confirmed the diagnosis of Swyer syndrome. Herein, we report a rare case of Swyer syndrome.

The Analysis of the $LH{\beta}$ Gene Mutation in Infertile Patients with Endometriosis and Amenorrhea Women (자궁내막증과 무월경 불임환자에서 $LH{\beta}$ 유전자의 돌연변이 분석)

  • Kim, Nam-Keun;Lee, Eu-Gene;Nam, Yoon-Sung;Lee, Sang-Hee;Chung, Ki-Wha;Ko, Jung-Jae;Lee, Sook-Hwan;Cha, Kwang-Yul
    • Clinical and Experimental Reproductive Medicine
    • /
    • v.27 no.1
    • /
    • pp.107-110
    • /
    • 2000
  • 연구목적: 본 연구는 자궁내막증과 무월경 불임환자들을 대상으로 $LH{\beta}$ exon 2 유전자의 돌연변이를 탐색하고자 시도하였다. 연구재료 및 방법: 그 대상으로 22명의 자궁내막증 환자와 12명의 무월경 환자 그리고, 54명의 건강한 비임신 여성을 대조군으로 사용하였다. 이들을 대상으로 한 돌연변이 탐색은 PCR-RFLP(polymerase chain reaction-restriction fragment polymorphism) 방법으로 수행되었다. 결과: 그 결과 자궁내막증과 무월경증 환자에서 그 변이의 비율이 각각 18.2%, 16.7% 그리고, 대조군에서 역시 16.7%의 빈도를 나타냈다. 결론: 따라서, 자궁내막증과 무월경증 환자는 $LH{\beta}$ exon 2 돌연변이와는 서로 관련이 없거나 매우 적음을 알 수 있었다.

  • PDF

Food Cravings, Appetite, and Taste Palatability in Women with Premenstrual Dysphoric Disorder (월경전 불쾌기분장애에 따른 맛 선호도 및 식품섭취 변화)

  • 정범석;김창윤;이철;장남수;김지명
    • Journal of Nutrition and Health
    • /
    • v.35 no.3
    • /
    • pp.314-321
    • /
    • 2002
  • Women with the premenstrual dysphoric disorder (PMDD) report increased cravings for certain foods and altered taste preferences ding the premenstrual period. The objective of the present study was to investigate the association of PMDD with luteal phase food cravings, appetite, and taste preferences in 1,078 nurses. Among the 626 nurses who gave valid responses, the prevalence of PMDD and premenstrual syndrome (PMS) was 4.6% (N = 29) and 78.3% (N = 490), respectively. A highly significant increase was observed in the preference for sweet tasting foods during the luteal phase, compared to the follicular phase. Desire for sweet foods during the premenstrual period was significantly different among the three groups, being highest in the PMDD group, lower in the PMS group, and lowest in women with no symptoms. Both the PMDD and PMS groups showed significant increases in preferences for pungent tasting foods during the luteal phase. A repeated measures of analysis of variance on the taste preference data revealed that the desire for sweet tasting foods was significantly greater than for others such as salty, sour, and pungent tastes. A greater proportion of the subjects in the PMDD and PMS groups reported an increase in their total food intake during the luteal phase, compared to those women without premenstrual symptoms. Compared to the PMS group or the women with no symptoms, the PMDD group reported increased intakes of high carbohydrate foods during the luteal phase. The most commonly reported food cravings were for sauteed spicy rice cakes (ddukbokki), or for cold buckwheat noodles mixed in chili pepper sauce. These results indicate that the luteal phase food cravings, appetite and taste preferences change in accordance with the severity of the premenstrual symptoms.

Effects of the Obesity Therapy with Korean Herbal Medicine on Menstrual Cycle Disorder: Case Series (한방비만치료가 월경주기 이상에 미치는 영향: 증례보고)

  • Lee, Ji-Hyeon
    • Journal of Korean Medicine for Obesity Research
    • /
    • v.18 no.1
    • /
    • pp.50-56
    • /
    • 2018
  • Obesity is associated with menstrual cycle disorder. The aim of this study was to investigate the clinical effect of the obesity therapy with Korean herbal medicine (KHM) on obese female patient with oligomenorrhea or amenorrhea. This is a retrospective observational study performed on obesity patients with oligomenorrhea or amenorrhea. Nine patients were treated with KHM and lifestyle management at least 2 months. During the treatment, body weight, body mass index (BMI), percent body fat (PBF) and menstrual cycle length were checked afterwards. Body weight, BMI, and PBF of the patients were decreased during treatments. Five of 9 subjects recovered to normal menstrual cycle. Two subjects improved menstrual cycle. The other subjects remained at oligomenorrhea or amenorrhea. This study shows that the obesity therapy including KHM could be effective to improve menstrual cycle on obese patient. Further large scale studies are necessary for more evidences.

A Case of 46XX, Primary Amenorrhea, Absent Gonads and Lack of Mullerian Ducts (46XX에서 원발성 무월경과 성선 결여를 동반한 뮬러관 이상 1예)

  • Lee, Bong-Ju
    • Clinical and Experimental Reproductive Medicine
    • /
    • v.28 no.2
    • /
    • pp.169-171
    • /
    • 2001
  • Objective: To study the etiology of primary amenorrhea in 19-aged woman. Materials and Methods: Case report. Results: I found that there were not gonads and organ of mullerian ducts origin on diagnostic laparoscopy. She was normal 46XX on chromosomal study and normal external genitalia except short vaginal canal. Conclusion: It is very rare that absent gonads and lack of mullerian ducts with 46XX female and primary amenorrhea.

  • PDF

Effects of Premenstrual Dysphoric Disorder on the Changes of Energy Intake and Body Composition (월경전 불쾌기분장애가 식이 섭취량 및 체구성 성분의 변화에 미치는 영향)

  • Chang, Un-Jae;Kim, Dong-Geon
    • Journal of the Korean Society of Food Science and Nutrition
    • /
    • v.34 no.2
    • /
    • pp.190-195
    • /
    • 2005
  • The purpose of this study was to identify the change of energy intake, blood sugar and body composition in accordance with menstrual cycle among the women with the premenstrual dysphoric disorder (PMDD) group and women with no premenstrual symptoms (NPS) group. Energy and carbohydrate intake were significantly increased in luteal and menstrual phases than follicular phase in both groups. Protein intake was significantly increased in luteal phase than follicular phase in both of groups. Fat intake was not difference in according to the menstrual phases in both groups. Weight and body water were significantly increased in luteal and menstrual phases than follicular phase in both groups. Fat mass was significantly increased in luteal phase than follicular phase in both groups. However, the differences in energy, carbohydrate, protein and fat intake, weight, body water and fat mass between groups were not significant. Above finding of this study showed that women's energy intake and body composition have connection with change of menstrual cycle and implied that more systematic study which affects menstrual cycle is requested.

The Resolution of Amenorrhea in Female Patients Taking Risperidone (리스페리돈을 복용한 여성 환자에서 유발된 무월경의 치료)

  • Lee, Bun-Hee;Kim, Yong-Ku;Han, Chang-Su;Ko, Young-Hoon
    • Korean Journal of Biological Psychiatry
    • /
    • v.10 no.2
    • /
    • pp.141-146
    • /
    • 2003
  • Objective:To find out the optimal assessment that can relieve amenorrhea associated with risperidone. Methods:Sixteen female outpatients who have taken risperidone for more than 3 months reported voluntarily amenorrhea during Nov 2001 to May 2002. Since the reports of the amenorrhea, the resolution of amenorrhea has been prospectively followed during the next six months. The dosage of risperidone was reduced or discontinued in nine of sixteen patients, while risperidone was switched to olanzapine or quetiapine in other 7 patients according to the clinician's decision. Results:Fourteen of 16 patients showed higher levels of prolactin than normal level. Five patients of the risperidone-reduction group recovered from the amenorrhea while all subjects of the drug-switch group recovered. The resolved patients of the former group recovered from amenorrhea in the dosage below 3mg per day of risperidone. Two patients of the risperidone-reduction group were dropped out during the reduction. Conclusion:These findings suggest that risperidone-induced amenorrhea may be alleviated by reducing dosage to less 3mg per day(including discontinuation) or by switching to other antipsychotic drugs. Whether we would choose which method depends on patient's clinical status, diagnosis, and dose of medication and so on.

  • PDF